| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $106,350 | 1 | 100 |
Sells | $0 | 0 | 0 |
| Parker Geoffrey M. | director | 1 | $106,350 | 0 | $0 | $106,350 |
Perrigo Company plc provides over-the-counter health and wellness solutions in the United States, Europe, and internationally. The company operates through Consumer Self-Care Americas and Consumer Self-Care International segments. It offers upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and oral electrolyte beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising …
Over the last 12 months, insiders at Perrigo Company plc have bought $106,350 and sold $0 worth of Perrigo Company plc stock.
On average, over the past 5 years, insiders at Perrigo Company plc have bought $1.29M and sold $2.61M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Parker Geoffrey M. (director) — $106,350.
The last purchase of 7,500 shares for transaction amount of $106,350 was made by Parker Geoffrey M. (director) on 2025‑11‑12.
| 2025-11-12 | Parker Geoffrey M. | director | 7,500 0.0054% | $14.18 | $106,350 | -4.44% | ||
| 2025-09-08 | Lennox Abigail | EVP and CSO | 1,255 0.0009% | $22.41 | $28,125 | -39.07% | ||
| 2025-09-05 | Atkinson Charles | EVP, General Counsel & Sec. | 1,000 0.0007% | $23.20 | $23,200 | -39.92% | ||
| 2025-08-22 | Willis Robert | EVP & CHRO | 1,488 0.0011% | $24.10 | $35,858 | -43.78% | ||
| 2025-08-18 | Bezerra Eduardo Guarita | EVP & Chief Financial Officer | 3,000 0.0022% | $22.74 | $68,207 | -40.18% | ||
| 2025-08-18 | Parker Geoffrey M. | director | 4,375 0.0032% | $22.97 | $100,497 | -40.18% | ||
| 2025-08-08 | Lockwood-Taylor Patrick | CEO | 4,460 0.0032% | $22.37 | $99,766 | -38.85% | ||
| 2025-05-12 | Parker Geoffrey M. | director | 3,500 0.0026% | $27.10 | $94,850 | -41.58% | ||
| 2025-03-10 | Sale | Janish Ronald Craig | EVP, Gbl Ops & SC & CTO | 7,800 0.0057% | $27.44 | $214,032 | -16.73% | |
| 2024-12-09 | Sale | KINDLER JEFFREY B | director | 17,598 0.013% | $28.27 | $497,495 | -10.09% | |
| 2024-09-13 | Sale | Doyle Katherine C. | director | 8,954 0.0065% | $27.30 | $244,444 | -4.94% | |
| 2024-08-26 | Sale | Janish Ronald Craig | EVP, Gbl Ops & SC & CTO | 13,000 0.0096% | $29.40 | $382,246 | -7.36% | |
| 2024-08-20 | Sale | Andersen Svend | EVP & President CHCI | 34,983 0.0255% | $27.69 | $968,560 | -2.24% | |
| 2024-05-28 | Andersen Svend | EVP & President CHCI | 1,000 0.0007% | $27.90 | $27,900 | -0.49% | ||
| 2024-03-05 | Ives Alison | EVP & Chief Scientific Officer | 2,490 0.0018% | $27.26 | $67,877 | +2.53% | ||
| 2024-03-01 | Willis Robert | EVP & CHRO | 371 0.0003% | $26.30 | $9,757 | +5.95% | ||
| 2024-02-29 | Willis Robert | EVP & CHRO | 6,000 0.0043% | $25.87 | $155,220 | +6.19% | ||
| 2024-02-29 | Lockwood-Taylor Patrick | CEO | 9,500 0.0071% | $26.54 | $252,168 | +6.19% | ||
| 2024-02-29 | Ives Alison | EVP & Chief Scientific Officer | 1,545 0.0011% | $26.44 | $40,850 | +6.19% | ||
| 2023-11-24 | Willis Robert | EVP & CHRO | 5,550 0.0041% | $31.01 | $172,106 | -5.15% |
| Parker Geoffrey M. | director | 17375 0.0126% | $272,787.50 | 9 | 0 | <0.0001% |
| Smith Jeffrey C | director | 3662220 2.6467% | $57.5M | 3 | 0 | <0.0001% |
| Lockwood-Taylor Patrick | CEO | 85812 0.062% | $1.35M | 3 | 0 | <0.0001% |
| KINGMA TODD W | Executive VP, General Counsel | 51856 0.0375% | $814,139.20 | 2 | 9 | <0.0001% |
| Bezerra Eduardo Guarita | EVP & Chief Financial Officer | 48949 0.0354% | $768,499.30 | 2 | 0 | <0.0001% |
| Willis Robert | EVP & CHRO | 41939 0.0303% | $658,442.30 | 4 | 0 | <0.0001% |
| SILCOCK RAYMOND | EVP, Chief Financial Officer | 37696 0.0272% | $591,827.20 | 1 | 0 | +8.29% |
| Alford Bradley A | director | 23978 0.0173% | $376,456.92 | 1 | 0 | +4.81% |
| Samuels Theodore R. II | director | 18118 0.0131% | $284,452.60 | 4 | 0 | <0.0001% |
| CLASSON ROLF A | director | 17442 0.0126% | $273,839.40 | 2 | 0 | +3.41% |
| Ives Alison | EVP & Chief Scientific Officer | 16122 0.0117% | $253,115.40 | 3 | 0 | +3.28% |
| Sorota Richard S | EVP & President CSCA | 7513 0.0054% | $117,954.10 | 1 | 0 | <0.0001% |
| Roehrhoff Uwe | CEO | 7500 0.0054% | $117,750.00 | 1 | 0 | <0.0001% |
| Andersen Svend | EVP & President CHCI | 7000 0.0051% | $109,900.00 | 6 | 1 | <0.0001% |
| KESSLER MURRAY S | CEO | 2668 0.0019% | $41,887.60 | 1 | 1 | <0.0001% |
| Lennox Abigail | EVP and CSO | 1255 0.0009% | $19,703.50 | 1 | 0 | <0.0001% |
| Atkinson Charles | EVP, General Counsel & Sec. | 1000 0.0007% | $15,700.00 | 1 | 0 | <0.0001% |
| Wesolowski John | EVP, President Rx | 709 0.0005% | $11,131.30 | 1 | 4 | <0.0001% |
$1,279,728,023 | 131 | 10.76% | $3.05B | |
$25,613,591 | 65 | -3.30% | $12.27B | |
$14,599,168 | 59 | 12.79% | $1.66B | |
$102,709,455 | 46 | 30.55% | $1.45B | |
Perrigo Company plc (PRGO) | $73,762,556 | 45 | -9.99% | $2.17B |
| Increased Positions | 202 | +49.39% | 38M | +24.61% |
| Decreased Positions | 189 | -46.21% | 38M | -24.46% |
| New Positions | 85 | New | 10M | New |
| Sold Out Positions | 88 | Sold Out | 19M | Sold Out |
| Total Postitions | 422 | +3.18% | 155M | +0.15% |
| Price T Rowe Associates Inc /Md/ | $235,023.00 | 12.26% | 16.92M | +2M | +16.27% | 2025-09-30 |
| Vanguard Group Inc | $192,824.00 | 10.06% | 13.88M | -144,874 | -1.03% | 2025-09-30 |
| Blackrock, Inc. | $187,177.00 | 9.77% | 13.48M | +347,713 | +2.65% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $106,887.00 | 5.58% | 7.7M | +181,828 | +2.42% | 2025-09-30 |
| State Street Corp | $95,883.00 | 5% | 6.9M | -437,327 | -5.96% | 2025-09-30 |
| Neuberger Berman Group Llc | $79,561.00 | 4.15% | 5.73M | +2M | +54.36% | 2025-09-30 |
| Cooke & Bieler Lp | $51,121.00 | 2.67% | 3.68M | +381,290 | +11.56% | 2025-09-30 |
| Sound Shore Management Inc /Ct/ | $50,712.00 | 2.65% | 3.65M | +363,327 | +11.05% | 2025-09-30 |
| Thompson Siegel & Walmsley Llc | $50,404.00 | 2.63% | 3.63M | +1M | +56.12% | 2025-09-30 |
| Deprince Race & Zollo Inc | $49,102.00 | 2.56% | 3.54M | -1M | -22.5% | 2025-09-30 |